The Senate Committee on Health, Education, Labor and Pensions (HELP) held an oversight hearing yesterday on the Food and Drug Administration’s (FDA) system for approving a new class of drugs – biosimilars. The hearing was a significant step in making sure that the focus of the biosimilar approval process is ( more… )